Vitality Watch

⚠ Evidence note: Nutrition evidence is dominated by observational data with heavy confounding; trial endpoints are mostly surrogates, not lifespan.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

Food-Derived GLP-1R Agonists

Current understanding

Emerging preclinical work suggests certain edible plant compounds — notably citrus flavonoids from Changshan Huyou — can activate intestinal GLP-1 receptor signaling and reduce atherosclerotic and vascular-senescence endpoints in ApoE mice via the GLP-1R/PKA/CREB axis [animal-model]. No human trials yet demonstrate that dietary intake of these foods reproduces pharmacologic GLP-1RA effects on weight, glycemia, or cardiovascular outcomes; the framing as ‘natural GLP-1 agonists’ currently rests on rodent mechanism data [mechanism-plausible].

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical
Citrus Changshan Huyou extracts as natural GLP-1R agonists attenuate atherosclerosis via the GLP-1R/PKA/CREB pathway: a functional food perspective.
05-aug-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18